Wells Fargo’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-74,447
| Closed | -$3.57M | – | 6813 |
|
|
2020
Q1 | $3.57M | Sell |
74,447
-29,822
| -29% | -$1.43M | ﹤0.01% | 2481 |
|
|
2019
Q4 | $4.89M | Buy |
104,269
+27,904
| +37% | +$1.31M | ﹤0.01% | 2567 |
|
|
2019
Q3 | $1.81M | Buy |
76,365
+28,730
| +60% | +$679K | ﹤0.01% | 3375 |
|
|
2019
Q2 | $1.43M | Buy |
47,635
+12,010
| +34% | +$361K | ﹤0.01% | 3566 |
|
|
2019
Q1 | $798K | Sell |
35,625
-10,355
| -23% | -$232K | ﹤0.01% | 3997 |
|
|
2018
Q4 | $837K | Buy |
45,980
+38,385
| +505% | +$699K | ﹤0.01% | 3885 |
|
|
2018
Q3 | $137K | Sell |
7,595
-43,492
| -85% | -$785K | ﹤0.01% | 4993 |
|
|
2018
Q2 | $508K | Buy |
51,087
+35,874
| +236% | +$357K | ﹤0.01% | 4341 |
|
|
2018
Q1 | $81K | Sell |
15,213
-7,478
| -33% | -$39.8K | ﹤0.01% | 5143 |
|
|
2017
Q4 | $193K | Sell |
22,691
-1,151
| -5% | -$9.79K | ﹤0.01% | 4794 |
|
|
2017
Q3 | $348K | Buy |
23,842
+14,885
| +166% | +$217K | ﹤0.01% | 4448 |
|
|
2017
Q2 | $168K | Sell |
8,957
-498
| -5% | -$9.34K | ﹤0.01% | 4716 |
|
|
2017
Q1 | $202K | Buy |
9,455
+5,700
| +152% | +$122K | ﹤0.01% | 4639 |
|
|
2016
Q4 | $57K | Buy |
+3,755
| New | +$57K | ﹤0.01% | 5087 |
|